Accelerating the Fight against Malaria - World Malaria Day 2024 (News)
https://www.swisstph.ch/en/news/accelerating-the-fight-against-malaria-world-malaria-day-2024
In the last few years, efforts to curb malaria have unfortunately been stalling. In 2022, over 600,000 people died from malaria, primarily children under the age of 5 in sub-Saharan Africa. People liv
World Malaria Day 2024: Work together and accelerate the fight! (Blog)
https://www.swisstph.ch/en/impact-stories/world-malaria-day-2024-work-together-and-accelerate-the-fight/blog-id/81
In the recent past, progress to curb malaria have been stalling. In 2022, over 600,000 people died from malaria, primarily children under the age of 5 years in sub-Saharan Africa. People living in the
Improve citizens’ access to Romanian quality health services in remote areas (Projects)
https://www.swisstph.ch/en/projects/project-detail/project/improve-citizens-access-to-romanian-quality-health-services-in-remote-areas
Within the 2nd Swiss Contribution to selected EU Member States, Switzerland is to support a number of programmes (“Support Measures”) in Romania, including one programme in the amount of around CHF 10
154 Million Deaths Averted: Contribution of Vaccination over the Past 50 Years (News)
https://www.swisstph.ch/en/news/news-detail/news/154-million-deaths-averted-contribution-of-vaccination-over-the-past-50-years
In 1974, the World Health Organization (WHO) launched the Expanded Programme on Immunization (EPI), motivated by the progress made thanks to vaccination in eradicating smallpox. Now, 50 years later, W
New Treatment for Human Parasitic Worm Infections Shows High Efficacy (News)
https://www.swisstph.ch/en/news/news-detail/news/new-treatment-for-human-parasitic-worm-infections-shows-high-efficacy
Soil-transmitted helminth infections are caused by different species of parasitic worms, including whipworms, hookworms and roundworms. Worldwide, more than 1.5 billion people are infected with at lea
SumayaVac-1: Clinical Trial for New Malaria Vaccine (Page)
https://www.swisstph.ch/en/about/med/clinical-operations/sumayavac-1-clinical-trial-for-new-malaria-vaccine
SumayaVac-1: Clinical Trial for New Malaria Vaccine About Malaria Despite being preventable and curable, malaria continues to pose a significant burden in tropical and subtropical regions. This life-t
FarmCoSwiss | Swiss TPH Studies (Page)
https://www.swisstph.ch/en/projects/farmcoswiss
FarmCoSwiss Long-Term Health Study of and for People Working in Swiss Agriculture and Their Partners Our survey is currently closed for registration. The survey may be reopened to new participants at
Pediatric Praziquantel Consortium (Page)
https://www.swisstph.ch/en/about/med/clinical-operations/pediatric-praziquantel-consortium
Pediatric Praziquantel Consortium Development of a suitable pediatric praziquantel formulation with proven safety and efficacy for treating schistosomiasis in preschool-aged children Schistosomes, par
The acute effects of community violence on young children's regulatory, behavioral, and developmental outcomes in a low-income urban sample in... (Publications)
BACKGROUND: Existing research on the impacts of adversity on young children's psychological well-being has largely focused on household-level risk factors using observational methods in high-income co
Identification and characterization of FTY720 for the treatment of human African trypanosomiasis (Publications)
Screening of a focused library identified FTY720 (Fingolimod, Gilenya(R)) as a potent, selective anti-trypanosomal compound active against T.b. gambiense and T.b. rhodesiense, the causative agents of